Literature DB >> 8048421

Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs.

M Depierreux1, B Van Damme, K Vanden Houte, J L Vanherweghem.   

Abstract

A new cause of chronic interstitial fibrosis of the kidney, recently identified in Belgium, was found to be related to a slimming regimen that included Chinese herbs. Thirty-three biopsy-proven cases of this nephropathy are discussed, with special reference to the pathologic aspects. Extensive interstitial fibrosis with atrophy and loss of the tubules was the major lesion; it was predominantly located in the superficial cortex. The glomeruli were relatively spared. They nevertheless showed a mild collapse of the capillaries and wrinkling of the basement membrane. Thickening of Bowman's capsule was the rule. Interlobular and afferent arterioles showed thickening of their walls due to swelling of the endothelial cells. These aspects suggest that the primary lesions could be located in the vessel walls, leading to ischemia and interstitial fibrosis. On the other hand, they are characteristic enough to allow the pathologist to suspect the diagnosis even in the absence of an anamnesis of ingestion of Chinese herbs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048421     DOI: 10.1016/s0272-6386(12)80178-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  51 in total

Review 1.  Chinese herbal medicines.

Authors:  Kevin V Ergil; Elizabeth J Kramer; Anthony T Ng
Journal:  West J Med       Date:  2002-09

Review 2.  Review of the regulations for clinical research in herbal medicines in USA.

Authors:  Tony Yuqi Tang; Fang-Zhou Li; Janyne Afseth
Journal:  Chin J Integr Med       Date:  2014-11-27       Impact factor: 1.978

Review 3.  Rodent models of AKI-CKD transition.

Authors:  Ying Fu; Chengyuan Tang; Juan Cai; Guochun Chen; Dongshan Zhang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-27

4.  Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy.

Authors:  Bicheng Chen; Yongheng Bai; Mei Sun; Xiaojie Ni; Yunxiu Yang; Yirong Yang; Shaoling Zheng; Feifei Xu; Shengchuan Dai
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

5.  Aristolochic acid induces apoptosis of human umbilical vein endothelial cells in vitro by suppressing PI3K/Akt signaling pathway.

Authors:  Hong Shi; Jiang-min Feng
Journal:  Acta Pharmacol Sin       Date:  2011-07-18       Impact factor: 6.150

6.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Americans' use of dietary supplements that are potentially harmful in CKD.

Authors:  Vanessa Grubbs; Laura C Plantinga; Delphine S Tuot; Elizabeth Hedgeman; Rajiv Saran; Sharon Saydah; Deborah Rolka; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2013-02-14       Impact factor: 8.860

8.  Balkan endemic nephropathy and aristolochic acid I: an investigation into the role of soil and soil organic matter contamination, as a potential natural exposure pathway.

Authors:  Alexandra T Gruia; Camelia Oprean; Alexandra Ivan; Ada Cean; Mirabela Cristea; Lavinia Draghia; Roxana Damiescu; Nikola M Pavlovic; Virgil Paunescu; Calin A Tatu
Journal:  Environ Geochem Health       Date:  2017-12-29       Impact factor: 4.609

Review 9.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.